Squamous cell carcinoma of the hypopharynx represents a distinct clinical entity. Most
patients present with significant comorbidities and advanced‐stage disease. The overall …

OBJECTIVES: Squamous cell carcinoma (SCC) of the hypopharynx represents a distinct
clinical entity among other cancers of the head and neck region. Despite recent advances in …

This study seeks to evaluate treatment modalities, mortality after surgery, survival, and local
control rates for a consecutive cohort of patients with cancer of the hypopharynx treated …

Objectives: To evaluate our experience with total pharyngolaryngectomy in the treatment of
hypopharyngeal squamous cell carcinoma. Study Design: Retrospective analysis of …

Cancer of the hypopharynx is relatively rare and accounts for roughly 3% of all head and
neck cancers. Unfortunately, hypopharyngeal carcinoma has one of the worst prognosis of …

Carcinoma of the hypopharynx is uncommon, accounting for 4% of all malignancies of the
head and neck reported by the National Cancer Data Base and 7% of all malignancies of …

Introduction. Hypopharyngeal cancers have extensive submucosal spread, high risk of
nodal involvement and relatively high propensity of distant metastases. Contemporary …

Background Although the standard therapy for locally advanced hypopharyngeal cancer
remains surgery and postoperative radiotherapy (RT), alternative treatment approaches …

Squamous cell carcinoma of the hypopharynx remains a highly lethal disease. This article
documents our experience with 132 patients undergoing surgical management of squamous …

Background. Surgery for squamous cell carcinoma (SCC) arising or extending to the
hypopharynx is generally reserved for advanced disease or salvage. The prognosis of …